Effects of Melatonin on the Body Composition, Physical Performance, and Blood Erythrocyte Indexes of C57Bl/6J Mice Exposed to Continuous Illumination


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Male C57Bl/6J mice were exposed to daily 24-h illumination over 14 days and daily intragastrically received melatonin (1 mg/kg) or water (placebo). Controls were kept under standard day/night (14/10 h) conditions. Melatonin prevented the development of anemia in mice exposed to continuous illumination, which was proven by higher blood hemoglobin levels by the end of the experiment in melatonin-treated animals in comparison with the placebo group. Studies by the low-field NMR spectrometry detected lower lean body mass, total body water, and especially, fat content (by ~13%) in animals receiving placebo. Melatonin treatment led to an increase in the lean body mass and total body water on day 7 (in comparison with the placebo group) without affecting fat mass. On day 14 of continuous illumination, lean body mass increased in comparison with the corresponding parameter in the control and placebo groups. Melatonin had no effect on the physical endurance of mice exposed to continuous illumination (assessed by the grid hanging test).

Sobre autores

S. Michurina

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Autor responsável pela correspondência
Email: s.michurina@ngs.ru
Rússia, Novosibirsk

I. Ishchenko

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk

M. Korolev

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk

A. Letyagin

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences; Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk; Novosibirsk

L. Rachkovskaya

Institute of Clinical and Experimental Lymphology, Affiliated Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk

A. Khotskina

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk

N. Khotskin

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk

S. Maslennikova

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk

E. Zavjalov

Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences

Email: s.michurina@ngs.ru
Rússia, Novosibirsk


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies